Search Results - "Shobe, Kellie"

A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer by George, Daniel J., Halabi, Susan, Fleming, Mark T., Heath, Elisabeth I., Tutrone, Ronald F., Sutton, Linda, Whang, Young E., Lewis, Brian E., Humeniuk, Michael Sandon, Berry, William R., Harrison, Michael Roger, Hurrelbrink, Julia, Shobe, Kellie, Rasmussen, Julia, Anand, Monika, Reyes-Martinez, Marco, Howard, Lauren, Patierno, Steven R., Freedman, Jennifer A, Armstrong, Andrew J.

“…5015 Background: Abi Race was the first prospective parallel cohort study of abiraterone acetate plus prednisone (AAP) in Black and White men with metastatic…”
Get full text

A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer by George, Daniel J., Halabi, Susan, Heath, Elisabeth I., Sartor, A. Oliver, Sonpavde, Guru P., Das, Devika, Bitting, Rhonda L., Berry, William, Healy, Patrick, Anand, Monika, Winters, Carol, Riggan, Colleen, Kephart, Julie, Wilder, Rhonda, Shobe, Kellie, Rasmussen, Julia, Milowsky, Matthew I., Fleming, Mark T., Bearden, James, Goodman, Michael, Zhang, Tian, Harrison, Michael R., McNamara, Megan, Zhang, Dadong, LaCroix, Bonnie L., Kittles, Rick A., Patierno, Brendon M., Sibley, Alexander B., Patierno, Steven R., Owzar, Kouros, Hyslop, Terry, Freedman, Jennifer A., Armstrong, Andrew J.

“…Background Retrospective analyses of randomized trials suggest that Black men with metastatic castration‐resistant prostate cancer (mCRPC) have longer survival…”
Get full text

Evaluating the Efficacy and Use of Vein Visualization Equipment Among Clinical Nurses in an Intermediate Care Environment by Kanipe, William, Shobe, Kellie, Li, Yin, Kime, Mary, Smith-Miller, Cheryl A

“…This study compared traditional short peripheral catheter (SPC) insertion methods with 2 vein visualization equipment models among a general patient population…”
Get full text

Phase II trial of 6 months ADT/abiraterone acetate plus prednisone (AAP) and definitive radiotherapy (AbiRT) for men with intermediate to high risk localized prostate cancer by Koontz, Bridget F., Hoffman, Karen E., Healy, Patrick, George, Daniel J., Harrison, Michael Roger, Zhang, Tian, Lee, W. Robert, Berry, William R., Pugh, Thomas J, Corn, Paul Gettys, Bratt, LuEllen, Shobe, Kellie, Thornburg, Blair, Allen, Donna M., Brummer, Katie, Tojong, Beth, Hobbs, Bridget, Halabi, Susan, Armstrong, Andrew J.

“…Abstract only 11 Background: Combined external beam radiotherapy (RT) and androgen deprivation therapy (ADT) improves survival over RT alone for high risk…”
Get full text